CIAM
DTIL icon

Caitong International Asset Management’s Precision BioSciences DTIL Stock Holding History

Caitong International Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141 Buy
+18
New +$127 ﹤0.01% 2085

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Caitong International Asset Management's DTIL Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Precision BioSciences (DTIL) in Q2 2026: 18 shares worth $141. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings.

95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Caitong International Asset Management held 18 shares of Precision BioSciences worth $141 as of Q2 2026.
  • Precision BioSciences was a new Caitong International Asset Management position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2085 holding.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.